| Literature DB >> 27677604 |
Jing Sun1, Li Zhang2, Yujun He3, Kun Zhang3, Liping Wu3, Yongsheng Fan3, Zhijun Xie3.
Abstract
Traditional Chinese Medicine (TCM) is increasingly getting clinical application worldwide. But its theory like QI-Blood is still abstract. Actually, Qi deficiency and blood deficiency, which were treated by Si-Jun-Zi-Tang (SJZT) and Si-Wu-Tang (SWT) respectively, have characteristic clinical manifestations. Here, we analyzed targets of the ingredients in SJZT and SWT to unveil potential biologic mechanisms between Qi deficiency and blood deficiency through biomedical approaches. First, ingredients in SWT and SJZT were retrieved from TCMID database. The genes targeted by these ingredients were chosen from STITCH. After enrichment analysis by Gene Ontology (GO) and DAVID, enriched GO terms with p-value less than 0.01 were collected and interpreted through DAVID and KEGG. Then a visualized network was constructed with ClueGO. Finally, a total of 243 genes targeted by 195 ingredients of SWT formula and 209 genes targeted by 61 ingredients of SJZT were obtained. Six metabolism pathways and two environmental information processing pathways enriched by targets were correlated with 2 or more herbs in SWT and SJZT formula, respectively.Entities:
Year: 2016 PMID: 27677604 PMCID: PMC5039637 DOI: 10.1038/srep34328
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Research flow chart.
We analyzed targets of the ingredients in Si-Jun-Zi-Tang (SJZT) and Si-Wu-Tang (SWT) to unveil the difference and relationship in molecular biological mechanisms between Qi deficiency and blood deficiency through biomedical approaches. First, ingredients in SWT and SJZT were retrieved from TCMID database. Then a visualized network of KEGG pathways was constructed with ClueGO to unveil the difference and relationship between Qi and blood.
Figure 2Counts of ingredients and genes targeted by SWT and SJZT formulae.
(A) The herb-ingredient-target network of SWT; (B) The herb-ingredient- target network of SJZT; (C) comparison of count of ingredients and targets of SWT and SJZT; Red, SWT, Green, SJZT. In (A,B), the square nodes represent herbs, green round nodes represent ingredients and yellow round nodes represent targets (genes).
Figure 3Network of pathways enriched by genes targeted by SWT and SJZT.
ClueGO KEGG analysis of predicted targets of SWT and SJZT. GO terms are represented as nodes, and the node color depth represents different proportions of genes/proteins of SWT and SJZT in each grouped term, the node size represents the term enrichment significance. Edge represents the relationship between terms. Red nodes represent terms of SWT; green nodes represent terms (pathways) of SJZT; grey nodes represent common terms of the two formulae. Functionally related terms partially overlap.
Common pathways enriched by targets correlated withmore thanoneherbs.
| Formula | Herbs | Term of pathway | Category of pathway |
|---|---|---|---|
| SWT | Rhizoma Chuanxiong, Radix Angelicaesinensis, Radix RehmanniaePraeparata | beta-Alanine metabolism | Metabolism; Amino acidmetabolism |
| Rhizoma Chuanxiong, Radix Angelicaesinensis, Radix RehmanniaePraeparata | Histidine metabolism | Metabolism;Amino acid metabolism | |
| Rhizoma Chuanxiong, Radix Angelicaesinensis | Phenylalanine metabolism | Metabolism; Amino acid metabolism | |
| Rhizoma Chuanxiong, Radix Angelicaesinensis | Tyrosine metabolism | Metabolism; Amino acid metabolism | |
| Rhizoma Chuanxiong, Radix RehmanniaePraeparata | Ascorbate and aldarate metabolism | Metabolism; Carbohydrate metabolism | |
| Rhizoma Chuanxiong, Radix RehmanniaePraeparata | Glycolysis/Gluconeogenesis | Metabolism; Carbohydrate metabolism | |
| SJZT | Panax ginseng, Poriacocos | Calcium signaling pathway | Environmental Information Processing; Signal transduction |
| Panax ginseng, Poriacocos, Radix GlycyrrhizaePreparata | Neuroactive ligand-receptor interaction | Environmental Information Processing; Signaling molecules and interaction |
Disease associated pathways enriched by targets of SWT and SJZT (P value < 0.01).
| Category | GO Term (Pathway) | Rate of targeted genes in pathway (%) | ||
|---|---|---|---|---|
| Common pathway | SWT | SJZT | ||
| Viral carcinogenesis | 1.19E-03 | 64.25 | 49.42 | |
| Thyroid cancer | 2.91E-03 | 63.26 | 50.61 | |
| Chemical carcinogenesis | 8.67E-20 | 65.77 | 51.92 | |
| Legionellosis | 6.46E-04 | 62.84 | 53.86 | |
| Small cell lung cancer | 4.81E-07 | 61.67 | 61.67 | |
| Amphetamine addiction | 7.76E-05 | 83.33 | 16.67 | |
| p53 signaling pathway | 4.43E-03 | 80.79 | 35.91 | |
| Colorectal cancer | 3.27E-05 | 80.40 | 43.85 | |
| Choline metabolism in cancer | 5.20E-06 | 79.78 | 58.51 | |
| Bladder cancer | 3.74E-05 | 76.52 | 51.02 | |
| Hepatitis B | 1.01E-12 | 75.53 | 44.63 | |
| Pancreatic cancer | 7.90E-06 | 73.71 | 53.61 | |
| Different pathway | Non-small cell lung cancer | 9.96E-06 | 71.64 | 57.31 |
| Prostate cancer | 1.06E-09 | 71.35 | 52.32 | |
| Chagas disease (American trypanosomiasis) | 5.00E-05 | 70.09 | 38.23 | |
| Cocaine addiction | 1.66E-07 | 69.23 | 30.77 | |
| Chronic myeloid leukemia | 2.03E-04 | 68.82 | 45.88 | |
| Pathways in cancer | 2.44E-12 | 67.36 | 54.32 | |
| HTLV-I infection | 8.79E-07 | 66.33 | 48.88 | |
Figure 4Network of non-disease pathways enriched by SWT and SJZT.
ClueGO KEGG analysis of non-disease pathways of SWT and SJZT.GO terms are represented as nodes, and the node color depth represents different proportions of genes/proteins of SWT and SJZT in each grouped term, the node size represents the term enrichment significance. Edge represents the relationship between terms. Red nodes represent terms of SWT; green nodes represent terms (pathways) of SJZT; grey nodes represent common terms of the two formulae.
Difference of non-disease associated pathways of SWT and SJZT(P value < 0.01).
| Formula | GO Term (Pathway) | Number of targeted genes | Category of pathway | |
|---|---|---|---|---|
| SWT | beta-Alanine metabolism | 15 | 1.55E-16 | Metabolism; Amino acid metabolism |
| Histidine metabolism | 11 | 2.24E-09 | Metabolism; Amino acid metabolism | |
| Phenylalanine metabolism | 9 | 5.93E-08 | Metabolism; Amino acid metabolism | |
| Tyrosine metabolism | 10 | 4.88E-07 | Metabolism; Amino acid metabolism | |
| Tryptophan metabolism | 10 | 2.94E-05 | Metabolism; Amino acid metabolism | |
| Ascorbate and aldarate metabolism | 11 | 1.93E-08 | Metabolism; Carbohydrate metabolism | |
| Pentose and glucuronateinterconversions | 10 | 9.88E-06 | Metabolism; Carbohydrate metabolism | |
| Glycolysis / Gluconeogenesis | 10 | 7.76E-05 | Metabolism; Carbohydrate metabolism | |
| Retinol metabolism | 16 | 3.96E-16 | Metabolism; Metabolism of cofactors and vitamins | |
| SJZT | Neuroactive ligand-receptor interaction | 23 | 3.60E-10 | Environmental Information Processing; Signaling molecules and interaction |
| Calcium signaling pathway | 18 | 1.46E-06 | Environmental Information Processing; Signal transduction | |
| Gap junction | 9 | 7.89E-03 | Cellular Processes; Cellular commiunity | |
| Vascular smooth muscle contraction | 13 | 7.35E-03 | Organismal Systems; Circulatory system | |
| Bile secretion | 13 | 2.31E-06 | Organismal Systems; Digestive system | |
| Thyroid hormone signaling pathway | 12 | 4.69E-05 | Organismal Systems; Endocrine system | |
| Ovarian steroidogenesis | 10 | 2.61E-04 | Organismal Systems; Endocrine system | |
| Prolactin signaling pathway | 8 | 7.27E-03 | Organismal Systems; Endocrine system | |
| Oxytocin signaling pathway | 11 | 8.65E-03 | Organismal Systems; Endocrine system | |
| Serotonergic synapse | 12 | 3.60E-06 | Organismal Systems; Nervous system | |
| Linoleic acid metabolism | 7 | 2.39E-04 | Metabolism; Lipid metabolism | |
| Regulation of lipolysis in adipocytes | 8 | 5.56E-03 | Metabolism; Lipid metabolism |
Commonnon-disease associated pathways of SWT and SJZT (P value < 0.01).
| GO Term (Pathway) | Rate of targeted genes in pathway (%) | Category of pathway | ||
|---|---|---|---|---|
| SWT | SJZT | |||
| Estrogen signaling pathway | 7.70E-09 | 54.37 | 59.31 | Organismal Systems; Endocrine system |
| GnRH signaling pathway | 3.61E-04 | 55.71 | 62.68 | Organismal Systems; Endocrine system |
| PPAR signaling pathway | 7.79E-04 | 67.88 | 67.88 | Organismal Systems; Endocrine system |
| GABAergic synapse | 1.46E-03 | 64.59 | 40.37 | Organismal Systems; Nervous system |
| Arginine and proline metabolism | 3.50E-12 | 57.66 | 46.13 | Metabolism; Amino acid metabolism |
| Steroid hormone biosynthesis | 3.48E-12 | 64.07 | 64.07 | Metabolism; Lipid metabolism |
| Metabolism of xenobiotics by cytochrome P450 | 7.97E-20 | 65.08 | 50.62 | Metabolism; Xenobiotics biodegradation and metabolism |
| cAMP signaling pathway | 3.69E-10 | 54 | 60.75 | Environmental Information Processing; Signal transduction |
| TNF signaling pathway | 2.74E-06 | 64.7 | 53.92 | Environmental Information Processing; Signal transduction |
| Apoptosis | 1.03E-03 | 53.53 | 61.17 | Cellular Processes; Cell growth and death |
Different targets in pathways enriched by SWT and SJZT (P value < 0.01).
| Formula | Target (Genes/proteins) |
|---|---|
| SWT | |
| SJZT |